Usefulness of statin drugs in protecting against atrial fibrillation in patients with coronary artery disease
Authors:
- Samer JabbourSJSamer Jabbour
- Robert GoldbergRGRobert Goldberg
- Charles M BlattCBCharles M Blatt
- Thomas GraboysTGThomas Graboys
- Brian BilchikBBBrian Bilchik
- Shmuel RavidSRShmuel Ravid
- 1 December 2003
- journal article
- research article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 92 (12) , 1379-1383
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Cardiovascular Events and Their Reduction With Pravastatin in Diabetic and Glucose-Intolerant Myocardial Infarction Survivors With Average Cholesterol LevelsCirculation, 1998
- Prevention of Cardiovascular Events and Death with Pravastatin in Patients with Coronary Heart Disease and a Broad Range of Initial Cholesterol LevelsNew England Journal of Medicine, 1998
- Impact of Atrial Fibrillation on the Risk of DeathCirculation, 1998
- Antiatherothrombotic Properties of StatinsJAMA, 1998
- Primary Prevention of Acute Coronary Events With Lovastatin in Men and Women With Average Cholesterol LevelsJAMA, 1998
- Incidence of and Risk Factors for Atrial Fibrillation in Older AdultsCirculation, 1997
- The Effect of Pravastatin on Coronary Events after Myocardial Infarction in Patients with Average Cholesterol LevelsNew England Journal of Medicine, 1996
- Prevention of Coronary Heart Disease with Pravastatin in Men with HypercholesterolemiaNew England Journal of Medicine, 1995
- Independent Risk Factors for Atrial Fibrillation in a Population-Based CohortJAMA, 1994
- The epidemiology of heart failure: The Framingham StudyJACC, 1993